Farallon Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.7K | Hold |
10,000
| – | – | ﹤0.01% | 126 |
|
|
2025
Q1 | $123K | Hold |
10,000
| – | – | ﹤0.01% | 126 |
|
|
2024
Q4 | $132K | Hold |
10,000
| – | – | ﹤0.01% | 132 |
|
|
2024
Q3 | $193K | Hold |
10,000
| – | – | ﹤0.01% | 138 |
|
|
2024
Q2 | $205K | Hold |
10,000
| – | – | ﹤0.01% | 130 |
|
|
2024
Q1 | $238K | Hold |
10,000
| – | – | ﹤0.01% | 135 |
|
|
2023
Q4 | $216K | Buy |
+10,000
| New | +$216K | ﹤0.01% | 124 |
|